-+ 0.00%
-+ 0.00%
-+ 0.00%

Xtant Medical Holdings Acquires Exclusive U.S. Distribution Rights To Dilon Technologies' HEMOBLAST Bellows

Benzinga·04/13/2026 13:08:33
Listen to the news

Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, and Dilon Technologies, Inc., a medical device manufacturer, today announced that the companies have entered into an agreement whereby Xtant has acquired exclusive U.S. distribution rights to Dilon's HEMOBLAST® Bellows for high-performance hemostasis following certain surgical procedures.